Company intelligence / Profile preview

Hemoteq

Würselen, North Rhine-Westphalia, Germanyhemoteq.com ↗

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Hemoteq is a leading CDMO specializing in advanced surface coatings and drug-device combination products. The company has over two decades of expertise, holds more than 100 patents, and offers end-to-end services from R&D through regulatory strategy to commercial-scale manufacturing. It was acquired by Freudenberg Medical in August 2015 but continues operations under its own name as part of the Freudenberg Medical group. Hemoteq’s core offerings include specialty coatings for stents, catheters, cochlear implants, and market-leading drug-coated balloon catheters. The company operates according to ISO13485 standards.

Modalities: DeviceSmall moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Freudenberg MedicalFreudenberg Group

Beyond the preview

Go deeper on Hemoteq.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoteq.

Explore the full profile